CD3+ CD8+ splenocytes were isolated from mice bearing i.p. ID8-Vegf tumors and treated with 10 μg of IL-18 daily for 20 days, starting 10 days following tumor inoculation. This evidence concerns the gene IL18 and neoplasm.